No Data
No Data
Liansheng Chemical (301212.SZ) announced first-quarter results, net profit of 8.016 million yuan, a decrease of 76.32%
Liansheng Chemical (301212.SZ) released its report for the first quarter of 2024. The company's revenue was 1.35...
The disinfectant sector fluctuated and rose. Shanghai Zaiba and Limin shares were all closed and stopped, while Midland New Materials, Xilong Science, Guanghua Technology, Liansheng Chemical, and Lianchuang Co., Ltd. followed suit.
The disinfectant sector fluctuated and rose. Shanghai Zaiba and Limin shares were all closed and stopped, while Midland New Materials, Xilong Science, Guanghua Technology, Liansheng Chemical, and Lianchuang Co., Ltd. followed suit.
Liansheng Chemical (301212.SZ): The company's GBL, NMP, IPA and other products fall into the category of wet electronic chemicals
Gelonghui, February 22丨Liansheng Chemical (301212.SZ) said on the investor interactive platform that the company's GBL, NMP, IPA and other products fall into the category of wet electronic chemicals and can be used in manufacturing processes such as display panels, semiconductors, and solar cells.
Liansheng Chemical (301212.SZ): 2023 net profit pre-reduced by 53.00%-60.65%
Gelonghui, January 26 | Liansheng Chemical (301212.SZ) announced its 2023 annual results forecast. Net profit attributable to shareholders of listed companies during the reporting period was 72 million yuan to 86 million yuan, down 60.65%-53.00% from the same period last year; net profit profit after deducting non-recurring profit and loss was 67 million yuan to 81 million yuan, down 63.02%-55.29% from the same period last year. The main reason for the decline in 2023 performance: 1. Demand in the downstream market in 2023 fell short of expectations, and industry competition intensified, leading to a sharp drop in sales prices of the company's products
Liansheng Chemical (301212.SZ): No notice has been received from shareholders holding 5% or more of the company's shares to participate in the financial transfer business
Gelonghui, January 12丨Liansheng Chemical (301212.SZ) said on the investor interactive platform that up to now, the company has not received notifications from shareholders holding 5% or more of the company's shares to participate in the financial transfer business.
Liansheng Chemical (301212.SZ): Some existing products can be used in medicine and other fields
Gelonghui January 5 丨 An investor asked Liansheng Chemical (301212.SZ) on the investor interactive platform, “Can the company's products be used to produce drugs to fight influenza or mycoplasma infections and treatments?” The company replied that some of the company's existing products can be used in fields such as medicine, but it is unclear whether downstream customers have applications to fight influenza or mycoplasma infections. It is recommended that you pay attention to the information disclosed by downstream customers.
No Data